Two pharmaceutical companies, in conjunction with the American Cancer Society (AMS), announced a deal slashing the price of cancer drugs to six African countries.
Cipla and Pfizer announced earlier this year that a deal was signed, designed to generate significant health benefits in Africa.
The six countries to benefit from the deal are Ethiopia, Nigeria, Kenya, Uganda, Rwanda and Tanzania.
The deal enables patients in these countries to save up to 50 per cent on the current cost of cancer medication.
The AMS’s Dr Megan O’Brien is the chief organiser of the deal.
Dr O’Brien told BBC Newsday that these six countries were chosen as that is where it is believed the deal will have the greatest impact.